otc glp-1 drugs America's Poison Centers This gentle Research shows GLP-1 drugs are
Description
However, she called the osteoporosis finding an early signal, noting that I dont think its conclusive. Future research on GLP-1 medications should focus on the incidence of fractures, which bone density loss can increase risk of, she said

[DOI] [PubMed] [Google Scholar] 35.Drucker DJ The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications

AlluriAAMohan KurienMPokarNPMadarapuASadamSPuvvalaNet al

Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones

In addition, GLP-1 RAs were not associated with increased risk of suicide death, self-harm, or incident depression and anxiety-related disorders

iScience 2021, 24
